Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia by Michele Gottardi, Federico Mosna, Sergio De Angeli, Cristina Papayannidis, Anna Candoni, Marino Clavio, Cristina Tecchio, Andrea Piccin, Marta Campo dell’Orto, Fabio Benedetti, Giovanni Martinelli, Filippo Gherlinzoni

Get full text

P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. by Gian Luca Morelli, Carla Fili, Endri Mauro, Anna Maria Scattolin, Federico Mosna, Carmela Gurrieri, Gianpaolo Nadali, Albana Lico, Alessandra Sperotto, Eleonora DE Bellis, Mariagrazia Michieli, Teresa Aloisi, Davide Lazzarotto, Maria Elena Zannier, Erica Simeone, Daniel Alzetta, Giulia Battaglia, Chiara Callegari, Umberto Pizzano, Rikard Mullai, Luca Tosoni, Mario Tiribelli, Renato Fanin

Get full text

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) by Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino, Matteo Pelosini, Alessandra Romano, Leonardo Flenghi, Vittorio Ruggero Zilioli, Teresa Calimeri, Arianna Di Napoli, Manuela Zanni, Erica Finolezzi, Federico Mosna, Guido Gini, Giovanna Mansueto, Alice Di Rocco, Gabriella Tomei, Nicola Sgherza, Jacopo Olivieri, Luca Nassi, Francesco Piazza, Angelo Fama, Antonio Greco, Margherita Giannoccaro, Anna Maria Mazzone, Carlo Visco, Giacomo Loseto, Francesco Zaja, on behalf of the Fondazione Italiana Linfomi Postgraduate Master course

Get full text